Through triggering the expression of the PI3K regulatory subunit p85α, MLXIPL sustains the activity of the pro-oncogenic PI3K/AKT signaling pathway in hepatocellular cancer. The gene discussed is AKT1; the disease is hepatocellular carcinoma.